Author:
Norman C.,Zarrinkoub R.,Hasselström J.,Godman B.,Granath F.,Wettermark B.
Reference48 articles.
1. Drug and therapeutics committees: a Swedish experience;Sjöqvist;WHO Drug Inf,2002
2. Recent national and regional drug reforms in Sweden - implications for pharmaceutical companies in Europe;Wettermark;Pharmacoeconomics,2008
3. Swedish experience in ambulatory care with multifaceted national and regional drug reforms and initiatives: global relevance;Godman;Expert Rev Pharmacoecon Outcomes Res,2009
4. Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a Primary Care setting;Usher-Smith;Int J Clin Pract,2007
5. 5 Beishon J , McBride T , Scharaschkin A et al., National Audit Office. Prescribing Costs in Primary Care. 10 May 2007 -http://www.nao.ork.uk/publications/0607/prescribing_costs_in_primary_c.aspx"http://www.nao.org.uk/publications/0607/prescribing_costs_in_primary_c.aspx (accessed May 2007).
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献